Close Menu

NEW YORK – A federal judge has narrowed a patent infringement lawsuit filed by Fluidigm by dismissing some of the firm's claims against competitor IonPath. Fluidigm's allegations of direct infringement remain, however, and the court did leave open the possibility for the firm to file an amended complaint to address the deficiencies in the case.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.